What's New
Last Posted: May 30, 2020
- Engaging Men With BRCA-Related Cancer Risks: Practical Advice for BRCA Risk Management From Male Stakeholders
M Dean et al, AM J Men's Health, May 25, 2020 - How can Australia integrate routine genetic sequencing in oncology: a qualitative study through an implementation science lens
R O'Shea et al, Genetics in Medicine, May 28, 2020 - Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes
T Frebourg et al, EJHG et al, May 26, 2020 - Liquid biopsy for early stage lung cancer moves ever closer
C Rolfo et al, Nat Rev Clin Oncol, May 26, 2020 - Genomics-guided pre-clinical development of cancer therapies
HE Francies et al, Nature Cancer, May 2020 - Local cellular cues that influence the immunology of colorectal cancer treatment
GP Donaldson et al, Nature Medicine, May 25, 2020 - Diagnosing hereditary cancer predisposition in men with prostate cancer.
Pritzlaff Mary et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 May - MHC-I genotype and tumor mutational burden predict response to immunotherapy
AM Goodman et al, Genome Medicine, May 19, 2020 - Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
H Zhang et al, Nature Genetics, May 18, 2020 - Microbial DNA signature in plasma enables cancer diagnosis
A Dzutsev et al, Nat Rev Clin Oncology, May 2020 - Assessment of the Value of Tumor Variation Profiling Perceived by Patients With Cancer
P Butow et al, JAMA Network Open, May 14, 2020 - Clinical Application of Computational Methods in Precision Oncology- A Review
OA Panagiotou et al, JAMA Oncology, May 14, 2020 - Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden.
Qing Tao et al. Nature communications 2020 May (1) 2438 - Future directions for implementation science at the National Cancer Institute: Implementation Science Centers in Cancer Control.
Oh April et al. Translational behavioral medicine 2020 Mar - Immune-related adverse events of checkpoint inhibitors
MR Casals et al, Nature Rev did Primers
No hay comentarios:
Publicar un comentario